Crossject Société Anonyme 74C.F Stock
Crossject Société Anonyme Price Chart
Crossject Société Anonyme 74C.F Financial and Trading Overview
| Crossject Société Anonyme stock price | 1.94 EUR |
| Previous Close | 3.34 EUR |
| Open | 3.76 EUR |
| Bid | 3.96 EUR x 50000 |
| Ask | 4.07 EUR x 50000 |
| Day's Range | 3.76 - 3.76 EUR |
| 52 Week Range | 1.76 - 4.94 EUR |
| Volume | 183 EUR |
| Avg. Volume | 22 EUR |
| Market Cap | 143.18M EUR |
| Beta (5Y Monthly) | 1.240618 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.36 EUR |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
74C.F Valuation Measures
| Enterprise Value | 132.16M EUR |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 20.272003 |
| Price/Book (mrq) | 50.743244 |
| Enterprise Value/Revenue | 18.712 |
| Enterprise Value/EBITDA | -10.654 |
Trading Information
Crossject Société Anonyme Stock Price History
| Beta (5Y Monthly) | 1.240618 |
| 52-Week Change | 90.40% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 4.94 EUR |
| 52 Week Low | 1.76 EUR |
| 50-Day Moving Average | 3.51 EUR |
| 200-Day Moving Average | 3.69 EUR |
74C.F Share Statistics
| Avg. Volume (3 month) | 22 EUR |
| Avg. Daily Volume (10-Days) | 0 EUR |
| Shares Outstanding | 36.36M |
| Float | N/A |
| Short Ratio | N/A |
| % Held by Insiders | 23.98% |
| % Held by Institutions | 2.32% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | December 31, 2022 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | -157.96% |
| Operating Margin (ttm) | -188.13% |
| Gross Margin | -17.0040% |
| EBITDA Margin | -175.63% |
Management Effectiveness
| Return on Assets (ttm) | -25.79% |
| Return on Equity (ttm) | N/A |
Income Statement
| Revenue (ttm) | 7.06M EUR |
| Revenue Per Share (ttm) | 0.19 EUR |
| Quarterly Revenue Growth (yoy) | 17.80% |
| Gross Profit (ttm) | N/A |
| EBITDA | -12405000 EUR |
| Net Income Avi to Common (ttm) | -11157000 EUR |
| Diluted EPS (ttm) | -0.38 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 7.77M EUR |
| Total Cash Per Share (mrq) | 0.21 EUR |
| Total Debt (mrq) | 14.13M EUR |
| Total Debt/Equity (mrq) | 525.91 EUR |
| Current Ratio (mrq) | 1.639 |
| Book Value Per Share (mrq) | 0.074 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -5080350 EUR |
| Levered Free Cash Flow (ttm) | -11161000 EUR |
Profile of Crossject Société Anonyme
| Country | Germany |
| State | N/A |
| City | Dijon |
| Address | 6 Rue Pauline Kergomard |
| ZIP | 21000 |
| Phone | 33 3 80 54 98 50 |
| Website | https://www.crossject.com |
| Industry | Medical Instruments & Supplies |
| Sector(s) | Healthcare |
| Full Time Employees | 93 |
Crossject Société Anonyme develops needle-free injection systems. The company develops ZENEO, a needle-free, prefilled, and single-use auto-injector. Its under development drugs comprise Sumatriptan, which is used for of treatment migraines and cluster headaches; Epinephrine for treating anaphylactic shock; Hydrocortisone that is used for treatment of acute adrenal crisis; Midazolam for treating epileptic seizure; Naloxone used for treatment of opioid overdose; Methotrexate used for treatment of rheumatoid arthritis; and Terbutaline, for treating severe asthma crisis. The company was founded in 2001 and is based in Dijon, France.
Q&A For Crossject Société Anonyme Stock
What is a current 74C.F stock price?
Crossject Société Anonyme 74C.F stock price today per share is 1.94 EUR.
How to purchase Crossject Société Anonyme stock?
You can buy 74C.F shares on the Frankfurt exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Crossject Société Anonyme?
The stock symbol or ticker of Crossject Société Anonyme is 74C.F.
Which industry does the Crossject Société Anonyme company belong to?
The Crossject Société Anonyme industry is Medical Instruments & Supplies.
How many shares does Crossject Société Anonyme have in circulation?
The max supply of Crossject Société Anonyme shares is 38M.
What is Crossject Société Anonyme Price to Earnings Ratio (PE Ratio)?
Crossject Société Anonyme PE Ratio is now.
What was Crossject Société Anonyme earnings per share over the trailing 12 months (TTM)?
Crossject Société Anonyme EPS is -0.36 EUR over the trailing 12 months.
Which sector does the Crossject Société Anonyme company belong to?
The Crossject Société Anonyme sector is Healthcare.